WDNAWisdomTree BioRevolution Fund
3.82%
Distribution yield
As of 7/14/2026
0.08%
30-day SEC yield
As of 7/14/2026
0.45%
Net expense ratio
As of 7/15/2026
6/3/2021
Inception Date
Overview
Product Description
The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index. Learn more about the Index that WDNA is designed to track.
Why WDNA?
- Gain targeted exposure to companies that seek to benefit from the revolution in biology focused technologies
- Use to complement core portfolios with innovative growth megatrends in the biology space
- Satisfies demand for multi-sector genetics and biotechnology investments with strong growth characteristics
Fund Overview
Product Overview | As of 7/15/2026 |
|---|---|
| Expense Ratio | 0.45% |
| CUSIP | 97717Y618 |
| Total Assets (000) | $2,630.85 |
| Shares Outstanding | 130,000 |
| Distribution Yield | 3.82% |
| SEC 30-day Yield | 0.08% |
| Options Available* | No |
| Inception Date | 6/3/2021 |
| Fiscal Year End | 06/30 |
*Options are not suitable for all investors.
Trading Information | As of 7/14/2026 |
|---|---|
| 30-Day Average Volume | 1,523 |
| Implied Liquidity™ (Shares) | 558,406,751 |
| Implied Liquidity (000) | $11,259,647.83 |
| Lead Market Maker | Flow Traders |
| Related index Symbol | WTDNAN |
| NAV Symbol | WDNA.NV |
| Shares Out. Symbol | WDNA.SO |
Net Asset Value
Net Asset Value | As of 7/15/2026 |
|---|---|
| NAV | $20.237 |
| Change | $0.073 |
| Change % | 0.36% |
| Premium/Discount to NAV | 0.155% |
Closing Market Price
Closing Market Value | As of 7/14/2026 |
|---|---|
| Closing Market Price | $20.195 |
| Change | -$0.075 |
| Change % | -0.37% |
| Median Bid/Ask Spread (30-Day Avg.) | 0.74% |
Market Capitalization
Market Capitalization | As of 7/14/2026 |
|---|---|
| Total Market Capitalization ($ Trillion) | 4.44 |
| Fund MarketCap Breakdown | |
| Large Cap (> $10 Billion) | 49.51% |
| Mid Cap (≥ $2 Billion and ≤ $10 Billion) | 37.25% |
| Small Cap (< $2 Billion) | 13.25% |
Portfolio Characteristics
Portfolio Characteristics | As of 7/14/2026 |
|---|---|
| Dividend Yield | 0.53% |
| Price/Earnings | -24.23 |
| Estimated Price/Earnings | -42.63 |
| Price/Book | 3.74 |
| Price/Sales | 3.99 |
| Price/Cash Flow | -43.64 |
| Gross Buyback Yield | 0.82% |
| Net Buyback Yield | -2.66% |
The measures above refer to the underlying securities of the holdings in the Funds' portfolios and should not be considered reflective of the Funds' performance.
Growth of Hypothetical 10K
Results are not indicative of future performance.
Total Returns
Month End Performance (6/30/2026)
Cumulative | 1 Month | 3 Month | YTD | Since Inception* | |
|---|---|---|---|---|---|
| Underlying Index Returns | 12.30% | 18.40% | 21.98% | -12.04% | |
| NAV Returns | 12.21% | 18.27% | 21.76% | -12.32% | |
| Market Price Returns | 12.11% | 18.30% | 21.80% | -12.38% | |
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| Underlying Index Returns | 60.30% | 7.93% | -3.76% | N/A | -2.49% |
| NAV Returns | 59.81% | 7.87% | -3.81% | N/A | -2.56% |
| Market Price Returns | 57.13% | 7.83% | -3.85% | N/A | -2.57% |
Quarter End Performance (6/30/2026)
Cumulative | Since Inception* | ||||
|---|---|---|---|---|---|
| Underlying Index Returns | -12.04% | ||||
| NAV Returns | -12.32% | ||||
| Market Price Returns | -12.38% | ||||
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| Underlying Index Returns | 60.30% | 7.93% | -3.76% | N/A | -2.49% |
| NAV Returns | 59.81% | 7.87% | -3.81% | N/A | -2.56% |
| Market Price Returns | 57.13% | 7.83% | -3.85% | N/A | -2.57% |
*Fund inception Date 6/3/2021
Performance is historical and does not guarantee future results. Current performance may be lower or higher than quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.
WisdomTree shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Total Returns are calculated using the daily 4:00pm net asset value (NAV). Market price returns reflect the midpoint of the bid/ask spread as of the close of trading on the exchange where Fund shares are listed. Market price returns do not represent the returns you would receive if you traded shares at other times.
After Tax Returns
Month End Performance 6/30/2026
Cumulative | 1 Month | 3 Month | Since Inception* | ||
|---|---|---|---|---|---|
| After Tax Held | 12.21% | 18.27% | -14.17% | ||
| After Tax Sold | 7.23% | 10.81% | -10.10% | ||
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| After Tax Held | 57.19% | 7.15% | -4.22% | N/A | -2.96% |
| After Tax Sold | 35.30% | 5.78% | -3.00% | N/A | -2.07% |
Quarter End Performance 6/30/2026
Cumulative | Since Inception* | ||||
|---|---|---|---|---|---|
| After Tax Held | -14.17% | ||||
| After Tax Sold | -10.10% | ||||
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| After Tax Held | 57.19% | 7.15% | -4.22% | N/A | -2.96% |
| After Tax Sold | 35.30% | 5.78% | -3.00% | N/A | -2.07% |
*Fund inception Date 6/3/2021
Performance is historical and does not guarantee future results. Current performance may be lower or higher than quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.
WisdomTree shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Total Returns are calculated using the daily 4:00pm net asset value (NAV). Market price returns reflect the midpoint of the bid/ask spread as of the close of trading on the exchange where Fund shares are listed. Market price returns do not represent the returns you would receive if you traded shares at other times.
After-Tax Held Returns represent return on Fund shares after taxes on distributions and assumes Fund shares have not been sold. After-Tax Sold Returns represent returns on Fund shares after taxes on distributions and the sale of the Fund shares.
After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's individual tax rates and may differ from those shown.
In some cases the return after taxes may exceed the return before taxes due to an assumed tax benefit from any losses on a sale of fund shares at the end of the measurement period.
Country Allocation
Country | Weight (%) |
|---|---|
| United States | 86.13% |
| Germany | 3.19% |
| Switzerland | 2.99% |
| United Kingdom | 2.35% |
| Netherlands | 2.29% |
| Denmark | 1.89% |
| Belgium | 0.64% |
| Australia | 0.53% |
Holdings
As of 7/14/2026
Name | Weight (%) |
|---|---|
| Twist Bioscience Corp | 5.46 |
| Moderna Inc | 4.08 |
| Eli Lilly & Co | 4 |
| Johnson & Johnson | 3.03 |
| Immunome Inc | 2.46 |
| United Therapeutics Corp | 2.43 |
| Natera Inc | 2.38 |
| Tempus Ai Inc | 2.36 |
| Darling Ingredients Inc | 2.24 |
| 10X Genomics Inc-Class A | 2.21 |
| Remaining Portfolio | 69.35 |
*Holdings are subject to change without notice.
Sector Breakdown
As of 7/14/2026
Name | Weight (%) |
|---|---|
Health Care | 89.19 |
Materials | 5.2 |
Consumer Staples | 4.23 |
Energy | 1.38 |
*Sectors are subject to change without notice
Recent Distributions
Ex-Dividend Date | Record Date | Payable Date | Ordinary Income | Short Term Capital Gains | Long Term Capital Gains | Return of Capital | Total Distribution |
|---|---|---|---|---|---|---|---|
| 12/26/2025 | 12/26/2025 | 12/30/2025 | $0.77052 | $0.00000 | $0.00000 | $0.00000 | $0.77052 |
| 12/26/2024 | 12/26/2024 | 12/30/2024 | $0.10710 | $0.00000 | $0.00000 | $0.00000 | $0.10710 |
| 12/22/2023 | 12/26/2023 | 12/28/2023 | $0.13500 | $0.00000 | $0.00000 | $0.00000 | $0.13500 |
| 12/23/2022 | 12/27/2022 | 12/29/2022 | $0.06526 | $0.00000 | $0.00000 | $0.00000 | $0.06526 |
Thought Leadership
Christopher Gannatti, CFA
When Space Leaves the Blueprint and Enters the Economy
The space economy is entering a new era as falling launch costs unlock commercial opportunities across connectivity, data and defense. Christopher Gannatti introduces the WisdomTree Space Economy Fund (WSPC), designed to provide targeted exposure to the companies building the next generation of the global space economy.
- Space Economy
- Megatrends
Christopher Gannatti, CFA, Samuel Rines
The Other Direction: How AI Could Become the Operating System for Quantum Computing
AI could have a bigger impact on quantum computing before quantum has a meaningful impact on AI. Christopher Gannatti and Samuel Rines explain why that shift matters for investors and why the companies enabling both technologies may be the real opportunity.
- Quantum computing
- Megatrends
Christopher Gannatti, CFA
Battlefield-Proven: How the Drone Revolution Maps onto WisdomTree's Physical AI, Humanoids & Drones Strategy
Cheap drones are reshaping modern warfare and forcing investors to rethink the defense landscape. Christopher Gannatti explains why the WisdomTree Physical AI, Humanoids, and Drones Fund (WDRN) is designed to capture opportunities across battle-tested drones, counter-drone technologies, and the broader Physical AI ecosystem.
- Megatrends
Christopher Gannatti, CFA
The Drone Dominance Map: China's Lead, America's Response, and the Supply Chain That Will Determine the Outcome
China still dominates the global drone market, but the battle is shifting from hardware leadership to supply chain control. Christopher Gannatti explains why U.S. policy and private investment are building a domestic drone ecosystem—and why that transition could create compelling opportunities across the Physical AI value chain.
- Megatrends
Documents
Product
Collateral
Reports and Regulatory
Other Links and Documents
Important Risk Information
This information must be preceded or accompanied by a prospectus, click here to view or download prospectus. We advise you to consider the fund's objectives, risks, charges and expenses carefully before investing. The prospectus contains this and other important information about the fund. Please read the prospectus carefully before you invest.
There are risks associated with investing, including possible loss of principal. The Fund invests in BioRevolution companies, which are companies significantly transformed by advancements in genetics and biotechnology. BioRevolution companies face intense competition and potentially rapid product obsolescence. These companies may be adversely affected by the loss or impairment of intellectual property rights and other proprietary information or changes in government regulations or policies. Additionally, BioRevolution companies may be subject to risks associated with genetic analysis. The Fund invests in the securities included in, or representative of, its Index regardless of their investment merit and the Fund does not attempt to outperform its Index. The composition of the Index is governed by an Index Committee and the Index may not perform as intended. Please read the Fund’s prospectus for specific details regarding the Fund’s risk profile.
- Fund Distribution Yield - Fund Distribution Yield is calculated by annualizing the most recent Fund distribution and dividing by the current Fund NAV. The yield represents a single distribution from the Fund and does not represent the total returns of the Fund.
- SEC 30-day Yield – The yield figure reflects the dividends and interest earned during the period, after the deduction of the fund's expenses. This is also referred to as the "standardized yield"
WisdomTree Funds are distributed by Foreside Fund Services, LLC in the U.S. only.
Neither WisdomTree, Inc., nor its affiliates, nor Foreside Fund Services, LLC, or its affiliates provide tax advice. All references to tax matters or information provided on this site are for illustrative purposes only and should not be considered tax advice and cannot be used for the purpose of avoiding tax penalties. Investors seeking tax advice should consult an independent tax advisor.